Cryolife reported $80.94M in Operating Expenses for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Abbott ABT:US USD 8.64B 245M
Accuray ARAY:US USD 98.68M 9.3M
Atricure ATRC:US USD 93.97M 4.22M
Baxter International BAX:US USD 6.57B 3.18B
Becton, Dickinson and BDX:US USD 4.27B 165M
Boston Scientific BSX:US USD 2.81B 9M
Cardiovascular Systems CSII:US USD 70.58M 1.41M
Cryolife CRY:US USD 80.94M 5.14M
Edwards Lifesciences EW:US USD 916.6M 2.2M
Integra Lifesciences IART:US USD 321.46M 15.29M
Johnson & Johnson JNJ:US USD 17.97B 211M
Mesa Laboratories MLAB:US USD 54.75M 293K
Pfizer PFE:US USD 13.23B 2.41B
Resmed RMD:US USD 674.56M 15.22M
Stryker SYK:US USD 3.67B 50M
Surmodics SRDX:US USD 32.6M 604K
Tandem Diabetes Care TNDM:US USD 252.04M 39.54M
Teleflex TFX:US USD 554.34M 15.04M
Terumo 4543:JP JPY 180.43B 13.51B